Bright Minds Biosciences Inc. · CSE:DRUG
Commodore Capital LP reported a 7.20% stake in Bright Minds Biosciences Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Commodore Capital LP reported a 7.20% stake in Bright Minds Biosciences Inc., 500,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 7.20%
- Shares
- 500,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| COMMODORE CAPITAL LP | 7.20% | 500,000 |
| Commodore Capital Master LP | 7.20% | 500,000 |
Source
Related
- Bright Minds Biosciences Inc.
- Commodore Capital LP
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Feb 17, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026